163 related articles for article (PubMed ID: 2823620)
1. Detection of early pregnancy factor-like activity in women with gestational trophoblastic tumors.
Mehta AR; Shahani SK
Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):67-9. PubMed ID: 2823620
[TBL] [Abstract][Full Text] [Related]
2. Early pregnancy factor (EPF) as tumour marker in two patients with trophoblastic tumour.
Bojahr B; Straube W; Römer T
Arch Gynecol Obstet; 1993; 252(4):215-8. PubMed ID: 8390229
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
4. A study of early pregnancy factor activity in the sera of women with trophoblastic tumor.
Fan X; Yan L; Jia S; Ma A; Qiao C
Am J Reprod Immunol; 1999 Mar; 41(3):204-8. PubMed ID: 10326623
[TBL] [Abstract][Full Text] [Related]
5. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
Khoo SK; Daunter B
Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
Rutanen EM; Seppälä M
J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
[No Abstract] [Full Text] [Related]
7. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
Goldstein DP
Am J Obstet Gynecol; 1971 Jun; 110(4):583-7. PubMed ID: 4325820
[No Abstract] [Full Text] [Related]
8. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
Jones WB; Lehr M; Lewis JL
Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
[No Abstract] [Full Text] [Related]
10. [Case observations on the significance of early pregnancy factor as a tumor marker].
Bojahr B; Straube W; Reddemann H
Zentralbl Gynakol; 1993; 115(3):125-8. PubMed ID: 7682025
[TBL] [Abstract][Full Text] [Related]
11. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
Lösch A; Kainz C
Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
Horne CH; Rankin R; Bremner RD
Int J Gynecol Pathol; 1984; 3(1):27-40. PubMed ID: 6203853
[No Abstract] [Full Text] [Related]
14. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
[TBL] [Abstract][Full Text] [Related]
15. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
16. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report.
Vejerslev LO; Larsen G; Jacobsen M
Eur J Obstet Gynecol Reprod Biol; 1991 Jun; 40(1):73-7. PubMed ID: 1649776
[TBL] [Abstract][Full Text] [Related]
17. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
Luschin-Ebengreuth G; Petru E; Pickel H
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
[No Abstract] [Full Text] [Related]
18. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
[TBL] [Abstract][Full Text] [Related]
19. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
20. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
Sakuragi N
Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
[No Abstract] [Full Text] [Related]
[Next] [New Search]
